Biotech Values

[DewDiligence]

Worst Pharma/Biotech CEO 2008 and All Time

Editorial comment: I think the survey Adam Feuerstein just ran in theStreet.com, which is named in honor of INGN’s David Nance, is based on a faulty premise. In my opinion, the worst CEO is the one who loses the most underlying shareholder value for his company. By definition, a scam company such as INGN does not have a lot of underlying shareholder value to lose, and hence the CEO of such a company cannot logically be considered the worst.

Rather, the worst biotech CEO’s are the ones whose companies have good drugs, good drug candidates, or good technology, but the CEO's nevertheless find a way to screw up and leave shareholders in much worse shape than they should have.

***Note: the questions in this survey have no “other” category—please choose the name that comes the closest in your view. ***


Q1: Who is/was the worst pharma/biotech CEO in 2008?

a) Dan Bradbury of AMLN
b) Harvey Berger of ARIA
c) Mitch Gold of DNDN
d) Kelly Martin of ELN
e) Geoff Cox of GTCB
f) Howard Pien of MEDX
g) Gérard Le Fur of SNY
h) Bruce Carter of ZGEN


Q2: Who is/was the worst pharma/biotech CEO of all time?

a) Kevin Sharer of AMGN
b) Peter Dolan of BMY
c) Mitch Gold of DNDN
d) Donal Geaney of ELN
e) Geoff Cox of GTCB
f) Sam Waksal of IMCL
g) Ray Gilmartin of MRK
h) Hank McKinnell of PFE


To vote, please go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #110.